James Maitchen

Analyst

Morgan Stanley

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About James Maitchen

James Maitchen is recorded as Analyst at Morgan Stanley. James Maitchen has spoken on 2 investor events across 2 companies, most recently for ZEALAND PHARMA A/S on September 16, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize James Maitchen's recent investor-event appearances and cite the source events.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Morgan Stanley

Analyst

Transcript header (unverified)

Current

Company network

Recorded roles and call appearances connecting this person to public companies.

ZEALAND PHARMA A/S

1 appearance Latest appearance 2026-09-16

Zealand Pharma A/S/ADR

ZLDPF

1 appearance Latest appearance 2026-09-16

View calls and events

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Conference
Morgan Stanley Global Healthcare Conference (New York)

ZEALAND PHARMA A/S

2026-09-16
Conference Morgan Stanley Global Healthcare Conference (New York) Zealand Pharma A/S/ADR (ZLDPF)
2026-09-16